
Global pharmacogenomics market share forecast by region 2018 and 2028
North America's share of the global pharmacogenomics market in 2018 stood at some 51 percent. By 2028, this percentage is projected to decrease to under 49 percent. Pharmacogenomics is the science of how a patient's genes respond to certain drugs. It is becoming particularly important with the rise of precision medicine and personalized medicine.